Resverlogix Exceeds Full Enrollment for the Pivotal Phase 3 BETonMACE Clinical Trial
Mar 19, 2018 11:01 am UTC| Business
CALGARY, Alberta, March 19, 2018 -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has successfully surpassed the planned enrollment target of over 2,400 patients in the ongoing...
Mar 19, 2018 11:01 am UTC| Business
MIGDAL HAEMEK, Israel and DALLAS, Texas, March 19, 2018 - TowerJazz, the global specialty foundry leader, today announced the ramp to production of active-semi®'s high-voltage integrated motor controller and driver...
Alio Gold and Rye Patch Gold Announce Business Combination
Mar 19, 2018 11:00 am UTC| Business
VANCOUVER, British Columbia, March 19, 2018 -- Alio Gold Inc (TSX:ALO) (NYSE AMERICAN:ALO) (“Alio Gold” or the “Company”) and Rye Patch Gold Corp. (TSX-V:RPM) (OTCQX:RPMGF) (FWB:5TN) (“Rye Patch”) are pleased to...
Mar 19, 2018 11:00 am UTC| Business
According to a new report, loyalty programs have a higher influence on Gen Z and Millennial consumer spend than on Boomers (66% vs. 58%). However, younger consumers are less satisfied with their programs (30%) compared to...
Aileron Therapeutics Appoints Jeffrey A. Bailey to its Board of Directors
Mar 19, 2018 11:00 am UTC| Business
CAMBRIDGE, Mass., March 19, 2018 -- Aileron Therapeutics (NASDAQ:ALRN), the clinical-stage leader in the field of stapled peptides developing therapeutics for cancers and other diseases, today announced the appointment...
Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY ER®
Mar 19, 2018 11:00 am UTC| Business
AUSTIN, Texas, March 19, 2018 -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a drug development company, announced today that the U.S. Food and Drug Administration (FDA) will hold an Advisory Committee Meeting to discuss the...
Mar 19, 2018 11:00 am UTC| Business
DURHAM, N.C., March 19, 2018 -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced data from AdVance, the first large, multi-center study of...